Search Clinical Trials

Clinical Trials Search Results

The results of your search are listed below. To view the details of a trial or study, click on the see details >> link. Or start a new search.

Searched for: Chronic Myeloid Leukemia (ALL)

16 results total

Allogeneic Nonmyeloablative Hematopoietic Stem Cell Transplant for Patients with BCR-ABL Tyrosine Kinase Inhibitor Responsive Ph+ Acute Leukemia ? a Multi-Center Trial

See details >>

Principal Investigator: George Georges, MD

Study Number: 1581.00

Nonmyeloablative Hematopoietic Stem Cell Transplantation for Patients with High-Risk Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Phase II Trial of Combined Immunosuppression Before and After Transplantation

See details >>

Principal Investigator: Paul O'Donnell, MD, PhD

Study Number: 1667.00

A Multi-Center Phase III Study Comparing Nonmyeloablative Conditioning with TBI versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies

See details >>

Principal Investigator: Brenda Sandmaier, MD

Study Number: 1813.00

A Phase III Randomized, Multicenter Study Comparing G-CSF Mobilized Peripheral Blood Stem Cell with Marrow Transplantation from HLA Compatible Unrelated Donors

See details >>

Principal Investigator: Ann Woolfrey, MD

Study Number: 1860.00

A Multi-Center Study of Nonmyeloablative Conditioning with TBI or Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies with Post Grafting Immunosuppression with Tacrolimus and Mycophenolate Mofetil

See details >>

Principal Investigator: David Maloney, MD, PhD

Study Number: 1898.00

A Randomized Phase II Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD after Unrelated Donor G-CSF mobilized Peripheral Blood Mononuclear Cell (G-PBMC) Transplantation using Nonmyeloablative Conditioning for Patients with Hematologic Malignancies A Multi-Center Trial

See details >>

Principal Investigator: Brenda Sandmaier, MD

Study Number: 1938.00

Campath® (Alemtuzumab) Dose Escalation, Low-Dose TBI and Fludarabine Followed by HLA Class II Mismatched Donor Stem Cell Transplantation for Patients with Hematologic Malignancies: a Multicenter Trial

See details >>

Principal Investigator: Brenda Sandmaier, MD

Study Number: 1959.00

Transplantation of Haploidentical CD34+ Purified Peripheral Blood Stem Cells with NK-Cell Add-Back Following Conditioning with Total Body Irradiation, Thiotepa, Fludarabine, and OKT3

See details >>

Principal Investigator: Ann Woolfrey, MD

Study Number: 1965.00

A Prospective Trial to Evaluate the Role of In Vivo T Cell Depletion by Campath® (Alemtuzumab) in Reduction of Transplant Related Mortality in Transplantation from HLA-Class I or Class II Mismatched, Unrelated Donors

See details >>

Principal Investigator: Ann Woolfrey, MD

Study Number: 1981.00

Transplantation of Unrelated Umbilical Cord Blood for Patients with Hematological Diseases with Cyclophosphamide/Fludarabine/Total Body Irradiation Myeloablative Preparative Regimen

See details >>

Principal Investigator: Colleen Delaney, MD, MSc

Study Number: 2010.00

Displaying first 10 of 16 total results. Click to view all 16 results.

Search Options

Select a disease from the list below:

Limit results to studies enrolling:
Both Adults & Pediatrics Adults Pediatrics

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

Talk to your health care providers first before making decisions about your health care.
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2009 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy.